vs

Side-by-side financial comparison of BLACKBAUD INC (BLKB) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.

BLACKBAUD INC is the larger business by last-quarter revenue ($281.1M vs $164.7M, roughly 1.7× PTC THERAPEUTICS, INC.). BLACKBAUD INC runs the higher net margin — 11.1% vs -82.0%, a 93.0% gap on every dollar of revenue. On growth, BLACKBAUD INC posted the faster year-over-year revenue change (4.2% vs -22.7%). BLACKBAUD INC produced more free cash flow last quarter ($37.0M vs $-36.6M). Over the past eight quarters, BLACKBAUD INC's revenue compounded faster (-1.1% CAGR vs -11.5%).

Blackbaud, Inc. is a cloud computing provider that supports nonprofits, foundations, corporations, education institutions, healthcare organizations, religious organizations, and individual change agents. Its products focus on fundraising, website management, CRM, analytics, financial management, ticketing, and education administration.

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

BLKB vs PTCT — Head-to-Head

Bigger by revenue
BLKB
BLKB
1.7× larger
BLKB
$281.1M
$164.7M
PTCT
Growing faster (revenue YoY)
BLKB
BLKB
+26.9% gap
BLKB
4.2%
-22.7%
PTCT
Higher net margin
BLKB
BLKB
93.0% more per $
BLKB
11.1%
-82.0%
PTCT
More free cash flow
BLKB
BLKB
$73.6M more FCF
BLKB
$37.0M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
BLKB
BLKB
Annualised
BLKB
-1.1%
-11.5%
PTCT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
BLKB
BLKB
PTCT
PTCT
Revenue
$281.1M
$164.7M
Net Profit
$31.1M
$-135.0M
Gross Margin
59.2%
Operating Margin
18.3%
-43.3%
Net Margin
11.1%
-82.0%
Revenue YoY
4.2%
-22.7%
Net Profit YoY
620.3%
-104.8%
EPS (diluted)
$0.67
$-1.63

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BLKB
BLKB
PTCT
PTCT
Q1 26
$281.1M
Q4 25
$295.3M
$164.7M
Q3 25
$281.1M
$211.0M
Q2 25
$282.0M
$178.9M
Q1 25
$269.9M
$1.2B
Q4 24
$302.1M
$213.2M
Q3 24
$286.6M
$196.8M
Q2 24
$287.3M
$186.7M
Net Profit
BLKB
BLKB
PTCT
PTCT
Q1 26
$31.1M
Q4 25
$36.7M
$-135.0M
Q3 25
$47.5M
$15.9M
Q2 25
$26.5M
$-64.8M
Q1 25
$4.3M
$866.6M
Q4 24
$-346.4M
$-65.9M
Q3 24
$18.3M
$-106.7M
Q2 24
$21.2M
$-99.2M
Gross Margin
BLKB
BLKB
PTCT
PTCT
Q1 26
59.2%
Q4 25
58.3%
Q3 25
59.6%
Q2 25
59.7%
Q1 25
57.5%
Q4 24
53.8%
Q3 24
54.9%
Q2 24
56.0%
Operating Margin
BLKB
BLKB
PTCT
PTCT
Q1 26
18.3%
Q4 25
20.0%
-43.3%
Q3 25
19.4%
1.4%
Q2 25
20.3%
-19.5%
Q1 25
7.3%
82.5%
Q4 24
-121.5%
-76.2%
Q3 24
14.4%
-27.7%
Q2 24
14.4%
-21.5%
Net Margin
BLKB
BLKB
PTCT
PTCT
Q1 26
11.1%
Q4 25
12.4%
-82.0%
Q3 25
16.9%
7.5%
Q2 25
9.4%
-36.3%
Q1 25
1.6%
73.7%
Q4 24
-114.6%
-30.9%
Q3 24
6.4%
-54.2%
Q2 24
7.4%
-53.1%
EPS (diluted)
BLKB
BLKB
PTCT
PTCT
Q1 26
$0.67
Q4 25
$0.75
$-1.63
Q3 25
$0.98
$0.20
Q2 25
$0.55
$-0.83
Q1 25
$0.09
$10.04
Q4 24
$-6.82
$-0.85
Q3 24
$0.35
$-1.39
Q2 24
$0.41
$-1.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BLKB
BLKB
PTCT
PTCT
Cash + ST InvestmentsLiquidity on hand
$34.1M
$1.9B
Total DebtLower is stronger
Stockholders' EquityBook value
$34.6M
$-205.3M
Total Assets
$2.1B
$2.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BLKB
BLKB
PTCT
PTCT
Q1 26
$34.1M
Q4 25
$38.9M
$1.9B
Q3 25
$38.3M
$1.7B
Q2 25
$41.6M
$2.0B
Q1 25
$37.2M
$2.0B
Q4 24
$67.6M
$1.1B
Q3 24
$34.6M
$1.0B
Q2 24
$30.4M
$1.1B
Total Debt
BLKB
BLKB
PTCT
PTCT
Q1 26
Q4 25
$1.1B
Q3 25
Q2 25
Q1 25
Q4 24
$1.1B
Q3 24
$1.0B
Q2 24
$1.0B
Stockholders' Equity
BLKB
BLKB
PTCT
PTCT
Q1 26
$34.6M
Q4 25
$85.1M
$-205.3M
Q3 25
$108.2M
$-155.8M
Q2 25
$72.7M
$-206.5M
Q1 25
$17.5M
$-185.8M
Q4 24
$126.8M
$-1.1B
Q3 24
$544.8M
$-1.1B
Q2 24
$577.5M
$-980.2M
Total Assets
BLKB
BLKB
PTCT
PTCT
Q1 26
$2.1B
Q4 25
$2.4B
$2.9B
Q3 25
$2.1B
$2.6B
Q2 25
$2.6B
$2.6B
Q1 25
$2.1B
$2.7B
Q4 24
$2.5B
$1.7B
Q3 24
$2.6B
$1.8B
Q2 24
$3.0B
$1.9B
Debt / Equity
BLKB
BLKB
PTCT
PTCT
Q1 26
Q4 25
13.06×
Q3 25
Q2 25
Q1 25
Q4 24
8.50×
Q3 24
1.84×
Q2 24
1.78×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BLKB
BLKB
PTCT
PTCT
Operating Cash FlowLast quarter
$51.5M
$-34.3M
Free Cash FlowOCF − Capex
$37.0M
$-36.6M
FCF MarginFCF / Revenue
13.2%
-22.3%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
1.65×
TTM Free Cash FlowTrailing 4 quarters
$294.1M
$702.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BLKB
BLKB
PTCT
PTCT
Q1 26
$51.5M
Q4 25
$58.0M
$-34.3M
Q3 25
$139.2M
$-66.3M
Q2 25
$66.9M
$-58.3M
Q1 25
$1.4M
$870.1M
Q4 24
$73.6M
$-30.0M
Q3 24
$104.0M
$-77.0M
Q2 24
$53.1M
$-71.5M
Free Cash Flow
BLKB
BLKB
PTCT
PTCT
Q1 26
$37.0M
Q4 25
$55.0M
$-36.6M
Q3 25
$135.7M
$-69.7M
Q2 25
$66.3M
$-59.6M
Q1 25
$712.0K
$868.4M
Q4 24
$73.4M
$-33.8M
Q3 24
$102.9M
$-77.5M
Q2 24
$48.0M
$-78.8M
FCF Margin
BLKB
BLKB
PTCT
PTCT
Q1 26
13.2%
Q4 25
18.6%
-22.3%
Q3 25
48.3%
-33.1%
Q2 25
23.5%
-33.3%
Q1 25
0.3%
73.8%
Q4 24
24.3%
-15.8%
Q3 24
35.9%
-39.4%
Q2 24
16.7%
-42.2%
Capex Intensity
BLKB
BLKB
PTCT
PTCT
Q1 26
Q4 25
1.0%
1.4%
Q3 25
1.2%
1.6%
Q2 25
0.2%
0.7%
Q1 25
0.3%
0.1%
Q4 24
0.1%
1.8%
Q3 24
0.4%
0.3%
Q2 24
1.8%
4.0%
Cash Conversion
BLKB
BLKB
PTCT
PTCT
Q1 26
1.65×
Q4 25
1.58×
Q3 25
2.93×
-4.17×
Q2 25
2.53×
Q1 25
0.32×
1.00×
Q4 24
Q3 24
5.69×
Q2 24
2.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons